Tüm alıştırma soruları

A physician is evaluating a promotional brochure for a newly approved biologic agent for the prevention of cardiovascular events in high-risk patients. The brochure prominently features a bar graph illustrating a $40\%$ relative risk reduction (RRR) in the primary composite endpoint (nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death) over a 4-year period compared to placebo.

To better understand the data, the physician reviews the trial methodology in the accompanying package insert. In the clinical trial, the absolute risk of the primary composite endpoint in the placebo group was $20\%$ over 4 years. The medication was also associated with an increased incidence of injection-site reactions, with a calculated number needed to harm (NNH) of 25 over 4 years.

The physician is considering prescribing this biologic agent to a 55-year-old man with hyperlipidemia. Using a validated cardiovascular risk calculator, the physician estimates that this specific patient's absolute risk for experiencing the primary composite endpoint without the biologic treatment is $5\%$ over the next 4 years.

Assuming the relative risk reduction of the medication remains constant across different baseline risk levels, what is the calculated number needed to treat (NNT) to prevent one primary composite endpoint event over 4 years for a population with this patient's specific baseline risk profile?

A cross-sectional study is conducted to evaluate the intraocular pressure (IOP) in a population of $5,000$ healthy adults over the age of $40$. The collected IOP measurements are determined to follow a normal distribution with a mean of $15$ mm Hg. The researchers note that approximately $800$ participants ($16\%$ of the cohort) have an IOP greater than $18$ mm Hg.

Based on these findings, what is the variance of the intraocular pressure in this population?

A randomized, double-blind clinical trial evaluates the efficacy of a novel Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe atopic dermatitis. A total of $428$ patients are randomized into one of four treatment arms: JAK inhibitor 15 mg, JAK inhibitor 30 mg, an active comparator (dupilumab), and placebo. The primary outcome is the absolute reduction in the Eczema Area and Severity Index (EASI) score from baseline to week 16. The data for this continuous variable are determined to be normally distributed, and Levene's test confirms homogeneity of variances across the groups.

Researchers perform a one-way analysis of variance (ANOVA) to evaluate whether there is a statistically significant difference in the mean EASI score reduction among the treatment groups. The $F$-statistic is calculated by dividing the between-group mean square by the within-group mean square.

What is the within-group (denominator) degrees of freedom for this statistical test?

A clinical pharmacologist is reviewing the baseline characteristics and primary endpoints for a phase 3 multicenter trial of a novel monoclonal antibody targeting IL-6 in patients with seropositive rheumatoid arthritis. To construct the final statistical analysis plan, each outcome variable must be appropriately classified to determine the correct descriptive statistics and graphical representations. Match the clinical trial variables on the left with their most accurate statistical classifications and corresponding descriptive summaries on the right.

A team of nephrologists is conducting a retrospective cohort study involving $450$ patients with chronic kidney disease. The primary objective is to evaluate the relationship between baseline proteinuria severity—categorized as mild, moderate, or severe—and two distinct clinical outcomes over a $2$-year follow-up period:

1. The absolute decline in estimated glomerular filtration rate (eGFR) in $mL/min/1.73m^2$. Preliminary analysis of this continuous variable reveals it to be highly right-skewed.
2. The initiation of maintenance hemodialysis, recorded as a dichotomous 'yes' or 'no' variable.

The investigators are drafting their statistical analysis plan to evaluate these relationships across the three independent patient groups. Which of the following statements regarding the appropriate inferential statistical tests for this study are correct? (Select all that apply)

An internist is discussing a newly approved direct oral anticoagulant with a 72-year-old male patient who has non-valvular atrial fibrillation. The patient brings in a direct-to-consumer print advertisement he found in a magazine. The headline reads, "Cut your risk of a stroke by a third!"

To provide accurate counseling, the internist reads the detailed prescribing information included in the advertisement's inset. The data stems from a 2-year randomized clinical trial that enrolled a total of 8,000 patients. Half of the patients received standard warfarin therapy, and the other half received the new medication. Over the 2-year follow-up period, 240 patients in the warfarin group experienced an ischemic stroke, compared to 160 patients in the new medication group.

Based on the data provided in the advertisement's inset, what is the number needed to treat (NNT) with the new medication for 2 years to prevent one additional stroke compared to warfarin?

An internal medicine specialist is analyzing the published results of a multi-center randomized controlled trial to decide if a new antithrombotic drug should be added to the hospital formulary. The study compared the new drug against standard care over a $3$-year period.

The following event frequencies were observed in the trial:

*Note: Relative risk changes are calculated against the standard care baseline.

To assess the overall clinical utility, the specialist evaluates a composite outcome of "total major clinical events," defined as the sum of ischemic strokes and major bleeding episodes.

Calculate the net number of total major clinical events PREVENTED for every $10,000$ patients treated with the new antithrombotic instead of standard care over the $3$-year period.

A 29-year-old construction worker is brought to the emergency department after his lower extremities were pinned under a collapsed concrete beam for four hours. On presentation, his blood pressure is 110/70 mmHg, and his pulse is 112/min. Physical examination reveals tense, swollen, and exquisitely tender calves bilaterally. Initial laboratory studies show a serum creatinine of 2.8 mg/dL, potassium of 6.4 mEq/L, and creatine kinase of 55,000 U/L. Urinalysis reveals 3+ blood on the dipstick, but microscopy demonstrates 0 to 1 red blood cells per high-power field. Based on the clinical and laboratory findings, the predominant mechanism of cellular injury occurring in this patient's renal parenchyma is most directly mediated by which of the following processes?

A 70-year-old man is brought to the emergency department by his daughter due to a 2-day history of worsening confusion, lethargy, and a new onset of tremors. His medical history is significant for bipolar disorder, hypertension, osteoarthritis, and chronic kidney disease with a baseline serum creatinine of 1.4 mg/dL. Surgical history includes a right total knee arthroplasty 5 years ago. Social history is notable for occasional alcohol consumption, but he denies tobacco or illicit drug use. He lives alone but is visited frequently by his daughter. His prescribed home medications include lithium, lisinopril, and hydrochlorothiazide. The daughter reports that he experienced a severe bout of gastroenteritis with frequent vomiting and watery diarrhea that began four days ago and resolved yesterday. On physical examination, the patient is mildly disoriented to time and place. He has dry mucous membranes, decreased skin turgor, and a prominent coarse resting tremor in his bilateral upper extremities. Laboratory studies reveal a serum creatinine of 3.1 mg/dL.

Which of the following specific historical elements are MOST critical to elicit to identify the precipitants of this patient's acute neurological and renal presentation? (Select exactly 3)

Review the following patient presentations, each characterized by a distinct clinical history. Select the most likely underlying etiology or diagnosis that corresponds to each patient's specific exposure or medication history.

A 31-year-old male is admitted to the intensive care unit with acute-onset diffuse mucosal bleeding, petechiae across his torso, and severe fatigue. Vital signs are temperature $37.8^\circ\text{C}$ ($100.0^\circ\text{F}$), blood pressure $110/70\text{ mmHg}$, heart rate $105/\text{min}$, and respiratory rate $18/\text{min}$. Laboratory studies show:

- Leukocytes: $2,100/\mu\text{L}$
- Hemoglobin: $8.4\text{ g/dL}$
- Platelets: $24,000/\mu\text{L}$
- Prothrombin time: $19\text{ seconds}$
- Partial thromboplastin time: $46\text{ seconds}$
- Fibrinogen: $85\text{ mg/dL}$
- D-dimer: $>10,000\text{ ng/mL}$

Peripheral blood smear reveals numerous abnormal promyelocytes with bilobed nuclei, abundant granules, and multiple needle-like cytoplasmic inclusions. The underlying neoplastic process involves a chromosomal translocation that creates a fusion protein, which abnormally represses gene transcription. Based on the suspected molecular pathology, which of the following is the most appropriate next step in management?

A 61-year-old man comes to the emergency department complaining of sudden-onset, crushing substernal chest pain that radiates to his left jaw. The pain began 45 minutes ago while he was resting. His medical history is significant for hypertension, hyperlipidemia, and a myocardial infarction three months ago, for which he underwent placement of a drug-eluting stent in the left anterior descending artery. His medications include aspirin, clopidogrel, metoprolol, and atorvastatin. Two weeks ago, he was evaluated for persistent heartburn and was started on omeprazole. An electrocardiogram obtained upon arrival shows 3-mm ST-segment elevations in leads V1 through V4. Urgent coronary angiography reveals acute thrombosis of the previously placed stent. Which of the following mechanisms best explains the failure of this patient's antiplatelet therapy?

A collegiate athlete is evaluated by a physician because she has never experienced a menstrual period. The patient reports no medical issues and takes no medications. On physical examination, she has Tanner stage V breast development but notably sparse axillary and pubic hair. Pelvic examination reveals a shortened, blind-ending vaginal pouch. A subsequent transabdominal ultrasound confirms the absence of a uterus, cervix, and fallopian tubes. While cytogenetic testing is pending, which of the following is the most appropriate next step in laboratory evaluation?

A 28-year-old aid worker who recently returned from a disaster relief mission in a developing country presents to the emergency department with profuse, "rice-water" diarrhea and severe leg cramps. His blood pressure is 80/50 mm Hg, and his pulse is 125/min. Physical examination reveals deeply sunken eyes, dry mucous membranes, and delayed capillary refill. He is rapidly resuscitated with intravenous lactated Ringer's solution. Stool cultures subsequently grow curved, Gram-negative, oxidase-positive rods. The principal virulence factor of this pathogen causes the patient's symptoms through a precise, multi-step intracellular mechanism.

Arrange the following cellular events in the correct chronological order to describe the pathogenesis of this organism's primary exotoxin.

A 68-year-old man is evaluated on hospital day 6 for an abnormal laboratory result. He was admitted for a severe exacerbation of chronic obstructive pulmonary disease and has been receiving intravenous methylprednisolone, azithromycin, and subcutaneous unfractionated heparin for deep venous thrombosis prophylaxis. His admission platelet count was 260,000/mm³. Today's routine complete blood count reveals a platelet count of 115,000/mm³. Hemoglobin is 13.8 g/dL and leukocyte count is 9,500/mm³. Vital signs are within normal limits. Physical examination reveals no petechiae, purpura, or new extremity swelling. The physician immediately discontinues the subcutaneous heparin and initiates therapeutic anticoagulation with argatroban. Which of the following is the most appropriate next step in laboratory evaluation?

A 28-year-old woman is brought to the emergency department by her roommate due to severe confusion, profound weakness, and passing exceptionally large volumes of dilute urine for the past 48 hours. Her medical history is significant for a psychiatric condition managed with a medication that requires regular serum monitoring. She recently recovered from a mild diarrheal illness. Temperature is 37.1°C (98.8°F), blood pressure is 92/56 mm Hg, and pulse is 118/min. Mucous membranes are dry, and skin turgor is noticeably diminished. Laboratory results show:

Administration of 2 mcg of intravenous desmopressin (dDAVP) is performed. Two hours later, a repeat urine osmolality is 130 mOsm/kg. Which of the following best describes the fundamental cellular mechanism causing this patient's current laboratory abnormalities?

A 29-year-old woman with a history of generalized tonic-clonic seizures is evaluated in the outpatient clinic for progressive unsteadiness, double vision, and confusion over the past week. Three weeks ago, she had a breakthrough seizure. Her neurologist subsequently increased her daily dose of phenytoin from $300 \text{ mg}$ to $400 \text{ mg}$. Her previously stable steady-state serum phenytoin concentration was $14 \text{ mg/L}$ (therapeutic range: $10-20 \text{ mg/L}$). Today, physical examination reveals coarse horizontal nystagmus, a broad-based gait, and slurred speech. Laboratory analysis demonstrates a serum phenytoin concentration of $34 \text{ mg/L}$. Which of the following pharmacokinetic principles best explains the disproportionate rise in this patient's serum drug concentration?

A 68-year-old man is brought to the emergency department by his wife due to a 3-day history of worsening confusion, profound fatigue, nausea, and two episodes of vomiting. Earlier today, he complained that the lights in the house appeared to have "yellow halos" around them.

His past medical history includes heart failure with reduced ejection fraction, atrial fibrillation, hypertension, and osteoarthritis of the knees. His daily medications are digoxin, carvedilol, sacubitril-valsartan, spironolactone, and apixaban. He also takes over-the-counter ibuprofen as needed for knee pain. For the past two weeks, he has been experiencing a mild dry cough and sore throat, for which he started drinking large amounts of a traditional licorice root tea three times a day.

His temperature is 37.1°C (98.8°F), blood pressure is 158/92 mmHg, pulse is 48/min and irregular, and respirations are 14/min. Physical examination reveals a confused elderly man. Cardiopulmonary examination demonstrates an irregular rhythm with clear lungs. There is trace bilateral pedal edema.

Laboratory studies show:
- Sodium: 142 mEq/L
- Potassium: 2.6 mEq/L
- Chloride: 104 mEq/L
- Bicarbonate: 30 mEq/L
- Blood urea nitrogen: 24 mg/dL
- Serum creatinine: 1.0 mg/dL

An electrocardiogram shows atrial fibrillation with a slow ventricular response and frequent premature ventricular complexes.

Which of the following elements of the patient's history is the most likely precipitating cause of his current clinical presentation?

A 65-year-old man is evaluated in the clinic for a 5-month history of progressive, voluminous watery diarrhea, abdominal bloating, and a 9-kg (19.8-lb) weight loss. He reports having 5 to 7 loose bowel movements daily that occasionally awaken him from sleep. His past medical history includes essential hypertension, type 2 diabetes mellitus, and hyperlipidemia. His past surgical history is unremarkable. He is a retired accountant who lives with his wife, drinks 1 to 2 glasses of wine on weekends, and has not traveled outside of his home state in the past decade. His medications include metformin, atorvastatin, and olmesartan. The olmesartan was initiated 8 months ago to replace lisinopril, which was discontinued due to a persistent dry cough.

Physical examination reveals a temperature of 37.0°C (98.6°F), blood pressure of 118/74 mmHg, and a heart rate of 88/min. The abdomen is soft and non-tender with hyperactive bowel sounds. Skin turgor is slightly decreased.

Laboratory evaluation shows:
- Hemoglobin: 11.2 g/dL
- Leukocyte count: 6,500/mm³
- Potassium: 3.2 mEq/L
- Bicarbonate: 18 mEq/L
- Tissue transglutaminase (tTG) IgA antibody: Negative
- Total serum IgA: 180 mg/dL (Normal: 70-400 mg/dL)

Stool studies are negative for enteric pathogens, ova, and parasites. The fecal osmotic gap is low, consistent with secretory diarrhea.

Due to the persistent symptoms and weight loss, an upper endoscopy with duodenal biopsy is performed. The histopathology report reveals severe villous blunting and atrophy with a marked increase in intraepithelial lymphocytes.

Based on the clinicopathologic findings, a thorough review of which of the following elements of the patient's medical history is MOST critical for establishing the definitive etiology of his condition?

A 29-year-old woman is evaluated in the hospital for sudden-onset pleuritic chest pain and dyspnea. CT pulmonary angiography confirms an acute pulmonary embolism, and she is immediately started on a continuous intravenous unfractionated heparin infusion. Her past medical history is significant for three consecutive spontaneous first-trimester abortions. Vital signs are temperature 37.1°C (98.8°F), blood pressure 118/76 mmHg, pulse 102/min, and respirations 18/min. She is hemodynamically stable. The medical team strongly suspects an underlying antiphospholipid syndrome (APS) or other inherited thrombophilia. Which of the following is the most appropriate strategy for the diagnostic laboratory evaluation of this patient's suspected hypercoagulable state?